A blood test to detect biomarkers for Alzheimer’s disease could bring diagnosis into everyday clinical practice. This may in turn support earlier intervention approaches.
Related Posts
Looking for some help with today’s NYT Mini crossword? In that case, extra clues and the answers are right here…
Looking for help with today’s New York Times Wordle? Here are hints, clues and commentary to help you solve today’s…
Urban centers are on the frontlines of climate risks and will be forced to rethink everything from their infrastructure to…
Urban centers are on the frontlines of climate risks and will be forced to rethink everything from their infrastructure to…
Falling out of love is incredibly painful. It’s not something either partner ever wants, yet many couples go through. Here’s…
Instead of solving Maxwell’s equations from scratch every time, imagine training a model to deeply understand the underlying physics.
Here are 4 things to know about Saharan Dust Approaching the United States this week.
The African dust approaching the United States this week raises many questions. A meteorologist explains what you need to know…
The new target valuation is a steep drop from the $25 billion the nation’s largest digital bank fetched in 2021.
President Donald Trump has long used nicknames to denigrate his political foes. The nicknames haven’t always the cleverest, but that’s…